11 unknown, 4 completed, 3 recruiting, 2 withdrawn. 9 Phase 1, 8 Not applicable, 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Unknown 8, Withdrawn 1 |
| Not applicable | 8 | Recruiting 3, Completed 2, Active not recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 8 | Unknown 8 |
Follow Sensitivity and Specificity: new trials by email Literature Review of Sensitivity and Specificity trials Research Report on Sensitivity and Specificity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LOVING (Learning About Our Behavior is Valuable for Increasing Nurturing Relationships and Healthy Growth) RCT VIPP-SD-SingH, "Video-Feedback Intervention to Promote Positive Parenting and Sensitive Discipline Adapted for the Singapore Context with a Health Component", CARE-SD, "Caregiver Awareness of Relationships through E-learning for Sensitivity and Discipline", NeuroEducation for Parents - Child Development, Child Behavioral Problems | Not applicable | Recruiting | National University of Singapore | 624 | 2026-05-25 | 2026-07-07 |
| Pattern of Microbial Keratitis in Assiut University Hospital corneal scraping including direct smear, culture and sensitivity - Keratitis, Microbial Keratitis | Not yet recruiting | Assiut University | 100 | 2026-01-01 | 2026-01-05 | |
| Characterizing Diversity and Antifungal Resistance in Immunocompromised ICU Patients With Respiratory Tract Infections Complete blood count, C-reactive protein, urea, creatinine, Random blood glucose (RBG), aspartate aminotransferase (AST), alanine aminotransferase (ALT), CT chest - Immunocompromised ICU Patients With Respiratory Tract Infections | Not applicable | Recruiting | New Valley University | 250 | 2025-12-01 | 2026-07-30 |
| Ecological Momentary Intervention for Reward in Anhedonia Training of reward processing/sensitivity, Relaxation Training (PMR), Psychoeducation - Anhedonia, Anxiety | Not applicable | Recruiting | Philipps University Marburg | 60 | 2025-06-18 | 2026-01-09 |
| Study of Risk Factors for Intraductal Papillary Mucinous Neoplasms Degeneration at the Nancy CHRU (IPMN) Sensitivity and specificity of risk factors for degeneration of IPMNs - Study of Risk Factors for IPMNs Degeneration at the Nancy CHRU | Unknown | Central Hospital, Nancy, France | 57 | 2021-05-10 | 2021-05-25 | |
| Rapid Diagnosis of COVID-19 by Chemical Analysis of Exhaled Air Performance evaluation (sensitivity and specificity) for COVID-19 diagnosis of the Vocus PTR-TOF process - Covid19 | Not applicable | Completed | Hospices Civils de Lyon | 4600 | 2021-03-01 | 2022-06-01 |
| The Personalized Chinese Herb Formulas Over Hypertensive Bradyarrhythmia Safflower (Carthamus Tinctorius) IgG4 | Serum | Allergy, Atropine Sulfate - Hypertensive Heart Disease | Not applicable | Completed | Jun Xiao | 72 | 2020-01-20 | 2020-08-10 |
| Fungal Infection in Patients With Diabetic Foot Osteomyelitis fungal osteomyelitis culture and sensitivity - Diabetic Foot Osteomyelitis | Unknown | Assiut University | 100 | 2020-01-01 | 2019-08-01 | |
| Mechanism of Hypersensitivity Reactions to Iron Nanomedicines hypersensitivity reaction - Iron-deficiency | Completed | University Hospital, Basel, Switzerland | 42 | 2017-10-01 | 2020-02-25 | |
| Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy Evaluating atopy in infants, Evaluating TEWL and STS in adults - Atopic Dermatitis, Eczema | Not applicable | Withdrawn | National Jewish Health | 2017-09-30 | 2018-06-12 | |
| Efficacy of Family Programs for Improving Child and Family Health and Development Control, Sensitivity Intervention, Couples' Intervention - Behavior, Infant | Not applicable | Active not recruiting | Colorado State University | 1005 | 2017-01-11 | 2026-07-01 |
| CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML anti-CD33 CAR-NK cells - Acute Myelogenous Leukemia, Acute Myeloid Leukemia | Phase 1 / Phase 2 | Unknown | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 10 | 2016-10-01 | 2016-12-06 |
| CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma PCAR-019 (anti-CD19 CAR-T cells) - Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia | Phase 1 / Phase 2 | Unknown | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 10 | 2016-10-01 | 2016-10-25 |
| PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma anti-CD19 CAR-NK cells - Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia | Phase 1 / Phase 2 | Unknown | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 10 | 2016-09-01 | 2016-12-06 |
| CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor anti-MUC1 CAR-pNK cells - Hepatocellular Carcinoma, Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Unknown | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 10 | 2016-07-01 | 2016-12-06 |
| Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma PCAR-019 (anti-CD19 CAR-T cells) - Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia | Phase 1 / Phase 2 | Unknown | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 10 | 2016-07-01 | 2016-08-01 |
| CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma anti-CD7 CAR-pNK cells - Acute Myeloid Leukemia, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Phase 1 / Phase 2 | Unknown | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 10 | 2016-03-01 | 2016-12-06 |
| Treatment of Chemotherapy Refractory Multiple Myeloma by CART-138 CART-138 cells - Multiple Myeloma | Phase 1 / Phase 2 | Unknown | Chinese PLA General Hospital | 10 | 2013-06-01 | 2016-01-28 |
| Nipple-Areola Complex Sensitivity After the Section of Periareolar Dermis in Breast Reduction Section of Periareolar Dermis in Breast Reduction. - Sensitivity of Nipple-areolar Complex | Not applicable | Unknown | Universidade Federal de Pernambuco | 50 | 2013-06-01 | 2013-04-29 |
| Treatment of Relapsed and/or Chemotherapy Refractory CD33 Positive Acute Myeloid Leukemia by CART-33 CART33 cells, anti-CD33 CART, anti-CD33 CAR T cells - Relapsed Adult Myeloid Leukemia, Chemotherapy Refractory Adult Myeloid Leukemia | Phase 1 / Phase 2 | Unknown | Chinese PLA General Hospital | 10 | 2013-04-01 | 2016-01-28 |
Showing 20 of 22. Sign in to see all of them.
Hypersensitivity (3) · Leukemia, Lymphocytic, Chronic, B-Cell (3) · Leukemia, Prolymphocytic, B-Cell (3) · Lymphoma, Follicular (3) · Lymphoma, Large B-Cell, Diffuse (3) · Lymphoma, Mantle-Cell (3) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (3) · Leukemia, Myeloid, Acute (2) · Anemia, Iron-Deficiency (1) · Anhedonia (1) · Anxiety Disorders (1) · Asthma (1) · COVID-19 (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1)
PersonGen BioTherapeutics (Suzhou) Co., Ltd. (6) · Assiut University (2) · Chinese PLA General Hospital (2) · CHU de Reims (1) · Central Hospital, Nancy, France (1) · Colorado State University (1) · Hospices Civils de Lyon (1) · Jun Xiao (1) · National Jewish Health (1) · National University of Singapore (1) · New Valley University (1) · Philipps University Marburg (1) · Universidade Federal de Pernambuco (1) · University Hospital, Basel, Switzerland (1) · University of North Carolina, Chapel Hill (1)
China (9) · France (3) · Egypt (2) · United States (2) · Brazil (1) · Germany (1) · Singapore (1) · Switzerland (1)
Lin Yang, Ph.D. (3) · Anne E Rifkin-Graboi, PhD (1) · David Peden, MD (1) · E M Cummings, Ph.D. (1) · Esther H Steveling-Klein, Dr., MD (1) · Michelle Hernandez, MD (1) · Mostafa Haridy (1) · Pia Hauk, MD (1) · Samantha Murray-Perdue, Ph.D. (1) · Xin Liu, Ph.D. (1) · Xingbing Wang, Ph.D. (1)
PMID 28054442, PMID 25174587, PMID 34515338, PMID 41121171
2017 (1), R01HD087319 (1)